As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.
Latest
- Financial Oversight Draft Bill Gets Early Start on Democrats’ AI AgendaPYMNTS · 24 minutes ago
- ‘We’re losing to cottage cheese’: The protein-maxxing craze is hurting cream cheese salesMarketWatch · 31 minutes ago
- Former FBI Agent Pleads Guilty to Stealing $2.47 Million in Crypto From InvestigationsBitcoin Magazine · 45 minutes ago
- Smaller Retailers Fear Fuel Costs Will Dampen Holiday SalesPYMNTS · 48 minutes ago
- Steal Bitcoin, Lose Your Own BTC? Developer Floats Three Defenses Against Quantum AttacksCryptoPotato · 52 minutes ago
- BOJ’s Ueda: Consumer prices now around 3% and expected to rise further into early next yearForex Live · 59 minutes ago
- Futures Trading: The Complete Guide For BeginnersInvestingCube · 59 minutes ago
- Tech layoffs November update: Job cuts hit workers at Amazon, Angi, Block, Canva, and SquarespaceFast Company · 1 hour ago




